Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-031022

Director acquired 9,868 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lang James Paul Director 2025-06-11 Grant or award +9,868 399,320 D: show line 1 in the form
Loading xslF345X05/wk-form4_1749760525.xml…